De novo acute myeloid leukemia risk factors

被引:37
|
作者
Strom, Sara S. [1 ]
Oum, Robert
Gbito, Kplola Y. Elhor
Garcia-Manero, Guillermo [2 ]
Yamamura, Yuko
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
acute myeloid leukemia; epidemiology; risk factors; smoking; solvents; obesity; BODY-MASS INDEX; CIGARETTE-SMOKING; ADULT LEUKEMIA; MYELODYSPLASTIC SYNDROMES; OCCUPATIONAL EXPOSURE; LIFE-STYLE; BENZENE; MORTALITY; FEATURES; TOBACCO;
D O I
10.1002/cncr.27442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Acute myeloid leukemia (AML) is comprised of several bone marrow-based cancers and is the most common type of leukemia in the United States. The etiology of AML is not well understood. A case-control study was conducted at The University of Texas M. D. Anderson Cancer Center to investigate associations between lifestyle characteristics and the risk of AML in Texas. METHODS: This study included 638 adult patients with de novo AML (cases) and a group of 636 matched controls. Interviewer-administered questionnaires were used to collect demographic and occupational data. The distribution of cases by World Health Organization (WHO) subtype was 71 patients (11%) with recurrent cytogenetic abnormalities (AML-RCA), 134 patients (21%) with multilineage dysplasia (AML-MD), and 389 patients (61%) with AML not otherwise categorized (AML-NOC). Multivariate logistic regression analyses were performed among all AML cases and among both sexes and each WHO subgroup. RESULTS: Among men, heavy smoking (=30 pack-years; odds ratio [OR], 1.86) and occupational solvent exposure at low levels (OR, 2.87) or moderate/high levels (OR, 4.13) statistically significantly increased the risk of AML. Among women, obesity (OR, 1.62) and solvent exposure to low levels (OR, 2.73) or moderate/high levels (OR, 3.90) increased the risk of AML. Across WHO subtypes, obesity was associated with a statistically significantly increased risk of AML-RCA (OR, 3.15), whereas solvent exposure increased the risk in all subtypes at low levels (AML-RCA: OR, 4.11; AML-MD: OR, 2.54) and moderate/high levels (AML-RCA: OR, 5.13; AML-MD: OR, 3.02). A joint effect between smoking and solvent exposure was observed, and the highest risk was observed among smokers who had solvent exposure (OR, 4.51). CONCLUSIONS: The current results suggested that several factors play a role in AML predisposition with possible joint effects. Risk profiles for AML differed by sex and WHO subtype. Cancer 2012.(c) 2012 American Cancer Society.
引用
收藏
页码:4589 / 4596
页数:8
相关论文
共 50 条
  • [21] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
    Ley, Timothy J.
    Miller, Christopher
    Ding, Li
    Raphael, Benjamin J.
    Mungall, Andrew J.
    Robertson, A. Gordon
    Hoadley, Katherine
    Triche, Timothy J., Jr.
    Laird, Peter W.
    Baty, Jack D.
    Fulton, Lucinda L.
    Fulton, Robert
    Heath, Sharon E.
    Kalicki-Veizer, Joelle
    Kandoth, Cyriac
    Klco, Jeffery M.
    Koboldt, Daniel C.
    Kanchi, Krishna-Latha
    Kulkarni, Shashikant
    Lamprecht, Tamara L.
    Larson, David E.
    Lin, Ling
    Lu, Charles
    McLellan, Michael D.
    McMichael, Joshua F.
    Payton, Jacqueline
    Schmidt, Heather
    Spencer, David H.
    Tomasson, Michael H.
    Wallis, John W.
    Wartman, Lukas D.
    Watson, Mark A.
    Welch, John
    Wendl, Michael C.
    Ally, Adrian
    Balasundaram, Miruna
    Birol, Inanc
    Butterfield, Yaron
    Chiu, Readman
    Chu, Andy
    Chuah, Eric
    Chun, Hye-Jung
    Corbett, Richard
    Dhalla, Noreen
    Guin, Ranabir
    He, An
    Hirst, Carrie
    Hirst, Martin
    Holt, Robert A.
    Jones, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22): : 2059 - 2074
  • [22] Elderly patients with de novo acute myeloid leukemia (AML):: Prognostic factors in 132 cases.
    Luno, Elisa
    Sanzo, Carmen
    Jonte, Fermin
    Vicente, Jose Maria
    Carrera, Dolores
    Sole, Francesc
    Chamorro, Pablo
    Martinez, Araceli
    BLOOD, 2006, 108 (11) : 192B - 192B
  • [23] Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and de novo acute myeloid leukemia
    Martin-Cabrera, Pedro
    Jeromin, Sabine
    Perglerova, Karolina
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    HAEMATOLOGICA, 2017, 102 (04) : E125 - E128
  • [24] Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia
    Tamura, S
    Takemoto, Y
    Hashimoto-Tamaoki, T
    Mimura, K
    Sugahara, Y
    Senoh, J
    Furuyama, J
    Kakishita, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (06) : 1259 - 1262
  • [25] Prognostic Implication of Therapy-Related Acute Myeloid Leukemia after Comparative Analysis with De Novo acute Myeloid Leukemia
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Kim, Hee-Je
    Yahng, Seung-Ah
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    BLOOD, 2015, 126 (23)
  • [26] Distinct Mutation Landscapes Between Acute Myeloid Leukemia With Myelodysplasia-Related Changes and De Novo Acute Myeloid Leukemia
    Gao, Yajuan
    Jia, Mingnan
    Mao, Yueying
    Cai, Hao
    Jiang, Xianyong
    Cao, Xinxin
    Zhou, Daobin
    Li, Jian
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (05) : 691 - 700
  • [27] Philadelphia chromosome positive acute myeloid leukemia or de novo chronic myeloid leukemia-blast phase?
    Frankfurt, Olga
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 1 - 2
  • [28] Prognostic significance of β-catenin and topoisomerase IIα in de novo acute myeloid leukemia
    Chen, Chih-Cheng
    Gau, Jyh-Pyng
    You, Jie-Yu
    Lee, Kuan-Der
    Yu, Yuan-Bin
    Lu, Chang-Hsien
    Lin, Jen-Tsun
    Lan, Chieh
    Lo, Wan-Hsia
    Liu, Jacqueline Ming
    Yang, Ching-Fen
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (02) : 87 - 92
  • [29] SNP ARRAY ANALYSIS OF DE NOVO ACUTE MYELOID LEUKEMIA WITH NORMAL KARPOTYPE
    Ibanez, M.
    Doria, S.
    Sanchez-Izquierdo, D.
    Gomez-Segui, I
    Such, E.
    Barragan, E.
    Llop, M.
    Lopez-Pavia, M.
    Villamon, E.
    De Matteo, B.
    Baldominos, P.
    Andreu, R.
    Senent, L.
    Montesinos, P.
    Sanz Miguel, A.
    Cervera, J.
    HAEMATOLOGICA, 2015, 100 : 20 - 21
  • [30] Expression and prognostic significance of survivin in de novo acute myeloid leukemia (AML).
    Adida, C
    Recher, C
    Raffoux, E
    Daniel, MT
    Taksin, AL
    Rousselot, P
    Sigaux, F
    Degos, L
    Altieri, DC
    Dombret, H
    BLOOD, 2000, 96 (11) : 698A - 698A